4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
First Claim
Patent Images
1. A method of treatment of HCV comprising administering to a patient in need thereof, a combination of a compound of Formula I and a compound of Formula II:
1 Assignment
0 Petitions
Accused Products
Abstract
Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein,
produce a synergistic effect on the inhibition of HCV polymerase.
29 Citations
22 Claims
- 1. A method of treatment of HCV comprising administering to a patient in need thereof, a combination of a compound of Formula I and a compound of Formula II:
- 16. A composition comprising a compound of Formula I and a compound of Formula II, admixed with at least one carrier, diluent or excipient
- 18. A method of treatment of HCV by administering to a patient in need thereof a compound of Formula I and a compound of Formula II, further in combination with a NS3A HCV protease inhibitor
- 20. A method of treatment of HCV by administering to a patient in need thereof a compound of Formula I and a compound of Formula II, further in combination with an additional NS5B HCV polymerase inhibitor
Specification